Loading...
HomeMy WebLinkAboutzika-virus-prenatal-silverman-01242018-archiveThe Buzz on Zika: Should We Still Be Concerned? Bay Area Infectious Diseases Conference January 24, 2018 Neil S. Silverman, M.D. Center for Fetal Medicine and Women’s Ultrasound Clinical Professor, Obstetrics and Gynecology Division of Maternal-Fetal Medicine David Geffen School of Medicine at UCLA Aedes aegypti o Zika virus is transmitted to humans primarily through the bite of infected Aedes sp. mosquito •Nearly all Zika outbreaks due to aegypti & albopictus •These are the same mosquitoes that transmit dengue and chikungunya -Dengue and Zika are flaviviruses (YF) ; chikungunya: alphavirus -West Nile also arbovirus/flavivirus, but spread by Culex sp. •The mosquito vectors typically breed in domestic water- holding containers •Aegypti --high “vectorial capacity”: feeds primarily on humans, multiple humans in a single meal, lives close to humans , also daytime and nighttime feeders Background o About 20% of people infected with Zika virus become symptomatic o Among those with clinical illness •Symptoms mild, typically develop within 1 week from exposure, lasting several days to a week •Characteristic clinical findings: acute onset of fever, maculopapular rash, arthralgia, or conjunctivitis. •Severe disease requiring hospitalization is uncommon and fatalities are rare. o Guillain-Barré syndrome also has been reported at increased rates in patients following Zika infection Clinical Disease Brasil P et al. N Engl J Med 2016. DOI: 10.1056/NEJMoa1602412 Clinical Features of Zika Virus Infection in Pregnant Women. Brazil Zika Outbreak o May 2015: First infection in Brazil o October 2015: increase in microcephaly o Microcephaly is a very specific diagnosis, and typically unusual as an isolated finding: initially seen in newborns •On ultrasound, defined as HC < 3 SD for GA (SMFM, 2016)* •HC < 2 SD for GA should trigger more detailed eval and f/u o Microcephaly became an early trigger to search for Zika association, but spectrum of disease became apparent •Microcephaly can occur as a result of a fetal brain disruption sequence: this appears to be pathology of Zika infection * ref: Chervenak FA, et al, AJOG 1984 Microcephaly: the tip of the iceberg? Zika virus intrauterine infection causes fetal brain abnormality and microcephaly: tip of the iceberg? Ultrasound in Obstetrics & Gynecology Volume 47, Issue 1, pages 6-7, 5 JAN 2016 DOI: 10.1002/uog.15831 http://onlinelibrary.wiley.com/doi/10.1002/uog.15831/full#uog15831-fig-0002 CT Scans Reveal Extensive Abnormalities Hazin et al, NEJM April 6, 2016 •Intracranial calcifications •Global cortical hypogyration •Ventriculomegaly •Global cerebellar hypoplasia 23 infants with microcephaly in Pernambuco, Brazil Fig 3 Severe microcephaly. Maria de Fatima Vasco Aragao et al. BMJ 2016;353:bmj.i1901 ©2016 by British Medical Journal Publishing Group Zika Associated Pregnancy Outcomes o Fetal loss/miscarriage, stillbirth o Fetal growth abnormalities o Fetal brain anomalies •Microcephaly •Ventriculomegaly •Intracranial calcifications o Eye abnormalities o Neurologic •Hypertonia •Arthrogryposis •Seizures Miranda-Filho et al, AJPH April 2016, Vol 106 No. 4 Ophtho criteria for CZS o First ophthalmological examination has to be performed within 30 days of birth. •Red Reflex Test does NOT work for diagnosis in cases of CZS •72 patients with CZS --normal RRT o SIGNS: Focal pigment mottling of the retina and circular lesions of chorioretinal atrophy including the macula, along with optic nerve abnormalities •Identified in 30% of newborns with microcephaly (Frietas et al, JAMA Ophtho 2/16) o UNIQUE CHORIORETINAL ATROPHY Zika-Related Arthrogryposis van der Linden at al, BMJ 8/16 Long Term Pregnancy Outcomes: Evolving o Update on 13 infants born without microcephaly but ZKV-infected (Brazil) •11 referred for small head size but > 2SD, 2 for devel. lag (5, 7 mos) •Neuroimaging abnormal in all: all w/ ↓ brain volume, +/or ↑ vents •10 w/dysphagia, 3 w/chorioretinitis, all hypertonic (MMWR 11/16) o Recent Brazil cohort Zin AA, et al. JAMA Pediatrics 7/17/17 •112 mother-infant pairs w/confirmed maternal infx •10/24 with eye findings (42%) did not have microcephaly, while 8 (33%) had no CNS findings o Anticipate a spectrum of outcomes? •Developmental and/or intellectual delay •Motor abnormalities o Brasil et al: Rio cohort1 •Prospective study cohort of134 symptomatic pregnant women with confirmed ZKV infection •Overall, 49/117 (42%) liveborn ZKV-exposed infants had abnormal findings by 1st month of life [5% in ZKV(-): p< 0.001] o Adverse outcomes seen regardless of trimester of infx •55% risk if maternal infx in 1st, 52% if in 2nd, 29% if in 3rd o Updated report from US Zika Pregnancy Registry2 •Birth defects related to Zika in 6%, 21 in live births •No risk difference regarding sx; 11% risk if exposure in 1st ∆ Pregnancy Risk Estimates 1. Brasil et al, NEJM 12/16. 2. Honein M et al, JAMA 12/13/16 December 15, 2017 ZODIAC Study: compiled comprehensive description of children > 12 months of age born with microcephaly (< 3rd %ile at birth) and (+) Zika IgM from Oct 2015-Jan 2016 19 infants, mean age at followup 22 months (range 19-24 months) 15/19 infants had HC ranging from 3.7-8.4 SD below the mean (avg 6.3 SD) All of these infants were symptomatic and had developmental testing < 6 mos. 4/19 infants had HC within 1 SD of mean, all had testing results for > 6 mos. Zika –Where is it and where is it not? As of Jan 2018: CDC.gov Zika as an Endemic Infection o Zika virus is considered endemic in some countries, and a large number of local residents are likely to be immune. However, US travelers to endemic areas may not be immune to Zika virus and infections have occurred among travelers to Asia and Africa o Zika evolving as an outbreak like other arboviruses : areas of endemicity but high potential (like West Nile and chikungunya) for ongoing sporadic cases and local outbreaks (Paules C, Fauci A: JAMA 1/12/17) Updated 5/17 Confirmed Zika Cases in Mexico by State January 1, 2016 –August 8, 2016 Sonora Chihuahua Coahuila Durango Nuevo León Yucatán Oaxaca Guerrer o Chiapas Colima Jalisco Nayarit Tabasc o Puebla Morelos 0 confirmed cases 1 –25 confirmed cases 26 –50 confirmed cases 51 –100 confirmed cases More than 100 confirmed cases Ag. = Aguascalientes Quer. = Querétaro DF = Distrito Federal Tl. = Tlaxcala Ag. Tl. Data provided by the Mexican Ministry of Health http://www.epidemiologia.salud.go b.mx/doctos/avisos/2016/zika/DG E_ZIKA_CASOS_SEM028_2016. pdf N = 1,490 Zika in the US: as of Jan 10, 2018 US States/DC (5635 cases): 407 in 2017 o Travel-associated Zika virus disease cases reported: 5355 (50 other routes) o Locally acquired vector-borne cases reported: 228 •In 2017: all travel cases, exc 4 local and 5 sexual US Territories o Travel-associated cases reported: 147 (0 in 2017) o Locally acquired cases reported: 36,976 (631 in 2017) •51 cases of Guillain-Barre syndrome CDC.gov Current Zika Statistics (as of 10/17/17) •2364 pregnant travelers with laboratory evidence of Zika virus in US States and DC –vast majority imported/travel-related o 2143 completed pregnancies o 102 reported liveborn infants and 9 fetal losses with Zika related birth defects (5.2% affected) •4690 pregnant cases in US territories (mostly Puerto Rico) ---3738 completed, 150 affected liveborns or losses (4.0%) Imported Zika Cases in California, 2015-17 (n = 609, through Nov 3, 2017, with 101 total in 2017 so far) Country Traveled To Number of Imported Cases in California (%) Mexico 195 (36%) Nicaragua 61 (11%) Guatemala 49 (9%) El Salvador 37 (7%) Dominican Republic 26 (5%) These 5 countries account for 68% of travel cases in CA Median age 35 66% in women Zika –Education and Testing o How much fetal risk with confirmed maternal infection? •Based on current data, range may be as high as 29% •Rates are derived from methodologically diverse studies o Despite earlier reports, recent data suggest later GA at infection does not exclude potential adverse impact o Pregnant women should not travel to areas with active local Zika transmission What do we tell our pregnant patients? o If in an area with transmission, protection and prevention strategies are important –and repellent for 3 weeks after return from these areas o DEET, picaridin fine for use in pregnancy •Consumer Reports (Sept 2017): Deet at 25-30% concentrations works best, picardin 20% (spray, not lotion), oil of lemon eucalyptus 30% (Repel better than Coleman) The role of prevention o While consequences of Zika infection are better understood, accurate diagnosis continues to be challenging •Virus present in body fluids only transiently •Serologic testing (IgM) can’t always reliably time infection •Serology prone to false-positive results and cross-reaction with other flaviviruses o With declining prevalence of Zika infection, probability of false-positive tests increases o Changing epidemiology further limits diagnostic capabilities of existing tests What informed the new testing guidelines? o Presumption has been that Zika infection confers immunity after the IgM response o Based on experience with other flaviviruses, previous Zika infection is likely to confer prolonged, likely lifelong immunity •If true, prior infection would prevent risks for a future pregnancy o However, no commercially-available IgG testing exists, and IgM duration limited o New tests on the horizon .. NS1-based Zika Immunity o As many areas in the Americas move into a 2nd or 3rd mosquito season after introduction of Zika virus, testing becomes more complex o Given the evolving epidemiology and the better- realized limitations of testing, updated testing algorithms for symptomatic and asymptomatic pregnant women emphasize a shared decision- making model o Need for pre-and post-test counseling, with results interpreted in context of limitations New guidelines –what do the changes reflect? o Screen pregnant women for Zika exposure risk and/or symptoms at every prenatal and hospital visit •Knowledge of potential exposure before and during pregnancy is critical information for test interpretation o Symptomatic pregnant women with recent possible Zika exposure: testing still recommended •Concurrent NAT (blood/urine) and IgM as soon as possible, through 12 weeks post-exposure (can consider if > 12 wks, but..) o Pregnant women with exposure and u/s findings: still test o Asymptomatic women with ongoing possible Zika exposure: testing still offered once/trimester •NAT testing of blood and urine, not IgM (diagnostic limits) New guidelines: what’s the same (mostly)? o Asymptomatic women with recent possible Zika exposure but not ongoing exposure •Testing now not routinely recommended for this group •BUT: shared-decision making and consideration of local/regional epidemiologic risks involved for this group •CDC acknowledges that data indicate that while perinatal Zika risk doesn’t differ by maternal symptoms, routine testing in a low-prevalence group increases risk of false- positives in absence of any prevention or therapies •If testing done, default to algorithm for symptomatic/no ongoing exposure: PCR and IgM o Until recently: CA, FL, TX, NY kept prior guidelines New guidelines: what’s different (mostly) Pregnancy Management o Microcephaly and intracranial calcifications typically detected during ultrasounds in the late 2nd/early 3rd ∆ •These birth defects might be detected as early as 18-20 weeks gestation. •A recent study of 17 pregnancies with laboratory confirmed Zika virus infection and adverse fetal outcomes reported a median of 18 weeks from symptom onset to prenatal diagnosis of microcephaly.(Paara-Saavedra et al, ObGyn 7/17) o If early testing negative and 2nd trimester or early 3rd trimester scan normal: usual care o If confirmed/possible maternal Zika infection, consider serial u/s q 3-4 weeks Zika “waiting periods” –not just pregnancy o Timeframes to wait to get pregnant after travel to an area with a CDC travel notice (CDC 7/17) •Women --8 weeks Men --6 months •If both partners traveled, wait 6 months + condoms o Egg and sperm donors (ASRM, 3/16) •Wait period 6 months after infx, travel, or contact o Blood donors (FDA, 2/16) •4 week waiting period Neonatal coordination is Critical! Need for Neonatal Followup & Deficits o Recent report on 2549 completed pregnancies (1/16-4/17) •5% of fetuses/newborns of women in Puerto Rico with confirmed Zika infection had likely Zika-associated birth defects 1 •Of liveborns without birth defects, only 52% had postnatal neuroimaging and 78% had hearing screens o Recent US Pregnancy Registry Data worse (MMWR, 4/7/17) 2 •Among 895 liveborns with maternal infection: postnatal neuroimaging reported for 25%, Zika testing of at least 1 infant specimen 65% o While 98% of pregnant women in P.R. in a recent survey took at least 1 measure to avoid Zika infection, use of repellents (45%) and condoms (40%) during pregnancy overall low 3 1. Shapiro-Mendoza CK, et al, MMWR 6/8/17. 2. Reynolds M et al, MMWR 4/7/17. 3. D’Angelo DV et al, MMWR 6/9/17 Which newborns need Zika surveillance? o Zika testing for in 1st two days after birth for infants at risk: serum and urine for PCR, serum for IgM •Mothers with lab-confirmed infection •Abnormal clinical findings suggestive of congenital Zika and potential maternal epidemiologic link, regardless of maternal test results o All infants born to women with lab-confirmed Zika infection should get: •Zika testing, comprehensive exam, head ultrasound, and standard hearing assessment •Based on newer data, they should also get formal eye exam (not just red reflex testing) o CDC Zika website: www.cdc.gov/zika o ACOG’s Zika webpage: www.acog.org/zika o CDC Zika Pregnancy Hotline for Healthcare Providers: 770-488-7100 or email ZikaPregnancy@cdc.gov for concerns related to clinical mgmt or the Zika Pregnancy Registry o CA Dept of Public Health webpage for health care professionals •www.cdph.ca.gov/zika Zika Resources